Lapsed Sep 11, 2024 on the fee record · Medium confidence
20-year base term ended Sep 17, 2024
Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.
Third maintenance fee unpaid; grace period ended.
Sep 17, 2004
Sep 11, 2024
Sep 11, 2012
Sep 17, 2024
Its term would have run to Sep 17, 2024: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 17, 2004, when application 10/943,799, the earliest non-provisional in its chain, was filed (this one was filed Feb 22, 2010) | Sep 17, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Sep 11, 2024 | High confidence |
| Computed term end | The steps above, in order | Sep 11, 2024 | Medium confidence |
This family
| US 7,744,861 | In force Dec 2026 | Dec 2026 |
| US 8,394,365 | Lapsed on the fee record Mar 2025 | Mar 2025 |
| Application 12/069,727 | Abandoned not computed | not computed |
| US 8,263,062 | this patent Sep 2024 | Sep 2024 |
| US 8,318,145 | Term ended no later than Sep 2024 | no later than Sep 2024 |
| US 8,771,662 | Term ended Sep 2024 | Sep 2024 |
| US 9,333,200 | Lapsed on the fee record May 2024 | May 2024 |
| US 9,808,533 | Term ended Sep 2024 | Sep 2024 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 17, 2012 Reel 28571, frame 141 | Nektar Therapeutics | Wells Fargo Bank, National Association, as Collateral Agent | Grant of Security Interest |
| Oct 6, 2015 Reel 36796, frame 562 | Nektar Therapeutics | TC Lending, LLC, as Collateral Agent | Grant of Security Interest in United States Patents |
| Oct 14, 2015 Reel 36866, frame 700 | Wells Fargo Bank, National Association, as Collateral Agent | Nektar Therapeutics | Release of Security Interest Recorded at Reel 28571, Frame 0141 |
| Apr 17, 2020 Reel 53180, frame 9 | TC Lending, LLC, as Collateral Agent | Nektar Therapeutics | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Sep 11, 2024. We will not guess the cap.